Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
deals
5
×
life sciences
national blog main
startups
5
×
boston
boston blog main
boston top stories
clinical trials
fda
investing
medical device
national top stories
new york blog main
san francisco blog main
san francisco top stories
480 biomedical
achaogen
adams street partners
allosteric
antibiotics
arsenal medical
atlas venture
atopic dermatitis
autoimmune disorders
azacitidine
beta lactamase inhibitor
beta-thalassemia
biomedical advanced research and development authority (barda)
bob langer
brace pharma
chronic rhinosinusitis
cleva pharma
covid-19
dacogen
decitabine
dna
drug delivery
drug discovery
drug resistance
What
therapeutics
5
×
disease
medicines
new
biotech
company
developing
drug
address
adds
ago
aims
allosteric
approach
bacteria
based
biopharma
building
business
called
clinic
deal
debut
debuts
developer
drugs
elusive
epigenetic
epigenetics
established
exited
field
fighting
firm
flagship’s
hotspot
infections
infectious
ipo
late
Language
unset
Current search:
therapeutics
×
startups
×
deals
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections
@xconomy.com
6 years ago
United Therapeutics Reaches $141M Deal for PAH Drug Firm SteadyMed